Physiological thyroid hormone levels regulate numerous skeletal muscle transcripts

J Clin Endocrinol Metab. 2009 Sep;94(9):3487-96. doi: 10.1210/jc.2009-0782. Epub 2009 Jun 30.

Abstract

Context: Skeletal muscle is an important target tissue for thyroid hormone (TH). It is currently unknown which genes are regulated by physiological TH levels.

Objective: We examined the effects of l-thyroxine on human skeletal muscle transcriptome.

Design: Microarray analysis of transcript levels was performed using skeletal muscle biopsies from patients under euthyroid and hypothyroid conditions.

Setting: The study was conducted in a university hospital laboratory.

Patients: We studied skeletal muscle obtained from 10 thyroidectomized patients with differentiated thyroid carcinoma on and after 4 wk off L-thyroxine replacement.

Mean outcome measures: Gene expression changes were measured using microarrays. Results were analyzed using dedicated statistical methods.

Results: We detected 607 differentially expressed genes on L-thyroxine treatment, of which approximately 60% were positively and approximately 40% were negatively regulated. Representative genes were validated by quantitative PCR. Genes involved in energy and fuel metabolism were overrepresented among the up-regulated genes, of which a large number were newly associated with thyroid state. L-thyroxine therapy induced a large down-regulation of the primary transcripts of the noncoding microRNA pair miR-206/miR-133b.

Conclusion: We demonstrated that physiological levels of TH regulate a myriad of genes in human skeletal muscle. The identification of novel putatively TH-responsive genes may provide the molecular basis of clinical effects in subjects with different TH status. The observation that TH regulates microRNAs reveals a new layer of complexity by which TH influences cellular processes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Gene Expression Regulation*
  • Glucose Transporter Type 5 / analysis
  • Hormone Replacement Therapy
  • Humans
  • Male
  • MicroRNAs / analysis
  • Middle Aged
  • Muscle, Skeletal / metabolism*
  • Oligonucleotide Array Sequence Analysis
  • Thyroxine / therapeutic use*

Substances

  • Glucose Transporter Type 5
  • MicroRNAs
  • SLC2A5 protein, human
  • Thyroxine